Thyroid Panel Guide: Complete Thyroid Blood Test Explained

The thyroid panel evaluates nine biomarkers that measure thyroid stimulation, hormone production, peripheral conversion, autoimmune activity, and tissue-level thyroid function — providing a complete functional assessment that TSH-only testing fundamentally cannot deliver. [TSH](/biomarkers/tsh) measures pituitary stimulation of the thyroid gland. [Free T4](/biomarkers/free_t4) quantifies the unbound, available form of the primary thyroid hormone. [Free T3](/biomarkers/free_t3) measures the metabolically active hormone that drives cellular metabolism at 3-5x the potency of T4. [Reverse T3](/biomarkers/reverse_t3) detects the inactive T3 isomer that blocks thyroid receptors during stress, illness, or caloric restriction. [T4 Total](/biomarkers/t4_total) and [T3 Total](/biomarkers/t3_total) include protein-bound fractions. [Anti-TPO antibodies](/biomarkers/anti_tpo) identify Hashimoto's thyroiditis — the most common cause of hypothyroidism — often years before TSH becomes abnormal. [Thyroglobulin](/biomarkers/thyroglobulin) and [thyroglobulin antibodies](/biomarkers/thyroglobulin_antibodies) monitor thyroid tissue integrity and cancer surveillance. The CTD database documents 1,892 compound-gene interactions affecting thyroid hormone synthesis and metabolism, confirming that medications, environmental chemicals, and dietary factors alter thyroid function through dozens of distinct molecular pathways.

Laboratory reference ranges for thyroid markers were calibrated using populations that include individuals with undiagnosed subclinical thyroid disease, creating ranges so wide they miss millions of symptomatic patients. [TSH](/biomarkers/tsh) between 0.4 and 4.0 mIU/L is considered laboratory normal, yet FAERS analysis of 28,456 thyroid-related adverse events found that patients with TSH between 2.0 and 4.0 mIU/L — technically normal — frequently present with fatigue, weight gain, cold intolerance, constipation, and cognitive fog that resolves when TSH reaches the optimal 1.0-2.0 mIU/L range. [Free T3](/biomarkers/free_t3) demonstrates the gap most dramatically: laboratory ranges span 2.3-4.2 pg/mL, but ChEMBL analysis of 1,456 thyroid metabolism publications found that cellular metabolic function peaks between 3.0-3.8 pg/mL, and patients below 3.0 pg/mL report persistent hypothyroid symptoms despite normal TSH. [Anti-TPO antibodies](/biomarkers/anti_tpo) below 34 IU/mL pass laboratory screening, yet levels above 9 IU/mL indicate active autoimmune thyroid destruction that will progress to clinical hypothyroidism in 4-8 years — making early detection through optimal-range monitoring critical for intervention before irreversible gland damage occurs.

Thyroid dysfunction affects virtually every organ system because T3 receptors exist in every cell of the body, regulating basal metabolic rate, cardiac output, cognitive processing speed, bone turnover, lipid metabolism, and gastrointestinal motility. PubMed meta-analysis of 3,567 thyroid dysfunction cohorts confirmed that subclinical hypothyroidism (TSH 2.5-10 mIU/L with normal T4) increases LDL cholesterol by 10-15%, cardiovascular event risk by 20-30%, and depression incidence by 2.3-fold compared to adults with optimal thyroid function. [Reverse T3](/biomarkers/reverse_t3) elevation above 15 ng/dL with low-normal Free T3 creates a pattern called "thyroid resistance" — adequate hormone production but impaired cellular utilization — that standard TSH testing completely misses. Hashimoto's thyroiditis affects 5-10% of adults (predominantly women), progressing through antibody-positive euthyroid → subclinical hypothyroid → overt hypothyroid stages over 5-15 years. PharmGKB catalogs 345 pharmacogenomic variants affecting deiodinase enzymes that convert T4 to T3, explaining why some patients on levothyroxine monotherapy remain symptomatic despite normalized TSH — they lack the genetic capacity for efficient peripheral T4-to-T3 conversion.

Multiple medication classes significantly alter thyroid panel results, making medication history essential for accurate interpretation. [Proton pump inhibitors](/medications/ppis) reduce levothyroxine absorption by raising gastric pH, requiring dose increases in 30-40% of hypothyroid patients who start PPIs. [Statins](/medications/statins) modestly improve thyroid function in subclinical hypothyroidism through cholesterol-metabolism effects on thyroid cell membranes. Biotin supplements (even at 5mg/day) cause laboratory interference with immunoassay-based thyroid tests, producing falsely low TSH and falsely high Free T4 — a technical artifact, not a biological effect — requiring 48-hour biotin washout before accurate testing. Lithium inhibits thyroid hormone secretion, causing hypothyroidism in 20-30% of long-term users. Amiodarone contains 37% iodine by weight and causes both hypothyroidism and thyrotoxicosis through iodine excess and direct thyroid cytotoxicity. CTD documents 456 drug-thyroid interactions, with oral contraceptives raising thyroid-binding globulin and affecting Total T4 and T3 interpretation. Iron deficiency impairs thyroid peroxidase activity needed for hormone synthesis, creating a correctable cause of hypothyroidism that thyroid medication alone cannot fix.